Shares of Carl Zeiss Meditec AG (ETR:AFX – Get Free Report) traded down 4.9% during mid-day trading on Thursday . The stock traded as low as €57.60 ($62.61) and last traded at €57.60 ($62.61). 266,723 shares changed hands during mid-day trading, an increase of 183% from the average session volume of 94,405 shares. The stock had previously closed at €60.55 ($65.82).
Carl Zeiss Meditec Stock Down 4.9 %
The company has a quick ratio of 2.47, a current ratio of 3.51 and a debt-to-equity ratio of 6.74. The company’s fifty day moving average is €62.88 and its 200-day moving average is €73.08. The company has a market cap of $5.15 billion, a PE ratio of 25.26, a PEG ratio of 2.83 and a beta of 0.98.
Carl Zeiss Meditec Company Profile
Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.
Recommended Stories
- Five stocks we like better than Carl Zeiss Meditec
- How to Use the MarketBeat Dividend Calculator
- Microsoft Can Hit New All-Time Highs This Year – Here’s Why
- How Investors Can Find the Best Cheap Dividend Stocks
- Zillow Stock’s Bull Case: Why This Recent Sell-Off Could Be a Buy
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- IonQ’s Quantum Surge: Ride the Wave or Cash Out?
Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.
